The Stanley Foundation brain collection and Neuropathology Consortium

Schizophrenia Research

Volumn 44, Issue 2, 2000, Pages 151-155

  Torrey, E Fuller ^a,b   Webster, Maree ^b   Knable, Michael ^a   Johnston, Nancy ^c   Yolken, Robert H ^c  

^a Stanley Foundation   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Brain bank; Depression; Neuropathology; Schizophrenia

Indexed keywords

ADULT; AGED; AUTOPSY; BRAIN TISSUE; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HEALTH CARE FACILITY; HEMISPHERE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; MEDICAL RECORD; NEUROPATHOLOGY; PRIORITY JOURNAL; RESEARCH; SCHIZOPHRENIA; SHORT SURVEY;

EID: 0034601620     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00192-9     Document Type: Article

References (11)

1. Brown C., Wang J.-F., MacQueen G., Young L.T. Increased temporal cortex ER stress proteins in depressed patients who died by suicide. Neuropsychopharmacology. 1999;. in press.
2. Caberlotto L., Hurd Y.L. Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder. NeuroReport. 10:1999;1747-1750.
3. Dowlatshahi D., MacQueen G.M., Wang J.-F., Young L.T. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet. 352:1998;1754-1755.
4. Dowlatshahi D., MacQueen G.M., Wang J.-F., Reiach J.S., Young L.T. G protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis suicide and treatment at the time of death. J. Neurochem. 73:1999;1121-1126.
5. Knable M.B. Schizophrenia and bipolar disorder: findings from studies of the Stanley Foundation Brain Collection. Schizophr. Res. 39:1999;149-152.
6. Ongur D., Drevets W.C., Price J.L. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc. Natl. Acad. Sci. USA. 95:1998;13290-13295.
7. Schramm M., Falkai P., Feldmann N., Knable M.B., Bayer T.A. Reduced tyrosine kinase receptor C mRNA levels in the frontal cortex of patients with schizophrenia. Neurosci. Lett. 257:1998;65-68.
8. Harrison P.J., Procter A.W., Barton A.J.L., Lowe S.L., Najlerahim A., Bertolucci P.H.F., Bowen D.M., Pearson R.C.A. Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Mol. Brain Res. 9:1991;161-164.
9. Harrison P.J., Heath P.R., Eastwood S.L., Burnet P.W.J., McDonald B., Pearson R.C.A. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci. Lett. 200:1995;151-154.
10. Johnston N.L., Cervenak J., Shore A.D., Torrey E.F., Yolken R.H. Multivariate analysis of RNA levels from postmortem human brains as measured by three different methods of RT-PCR. J. Neurosci. Meth. 77:1997;83-92.
11. Torrey E.F. Surviving Schizophrenia: A Family Manual. second ed. 1988;188 Harper Collins, New York.